Supplementary Table S3 from Overall Survival and Exploratory Biomarker Analyses of Abemaciclib Plus Trastuzumab with or Without Fulvestrant Versus Trastuzumab Plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients
openalex（2024）
Key words
Breast Cancer,Trastuzumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined